article thumbnail

The GoCART Coalition: Guidance for pharmacists

Hospital Pharmacy Europe

Guidance on the provision of CAR T and cellular therapy services in hospital pharmacy has been published by the GoCART Coalition to harmonise implementation across Europe. 10 Once the CAR T-cells are manufactured, they are delivered to hospital pharmacies, making pharmacists central in ensuring appropriate governance and management.

article thumbnail

NICE changes stance on Lilly’s breast cancer dug Verzenio

pharmaphorum

A final appraisal document from the health technology assessment (HTA) agency backs the use of Verzenio (abemaciclib) alongside fulvestrant for the treatment of women with hormone receptor-positive, HER2-negative breast cancer in England and Wales. .

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

NICE backs AZ’s Calquence for new use in leukaemia

pharmaphorum

AstraZeneca’s BTK inhibitor Calquence has become the first targeted oral therapy to be backed by NICE for NHS England patients with chronic lymphocytic leukaemia (CLL) who can’t be treated with first-line chemotherapy. The decision is at odds with the situation in Scotland, where Nilemdo was turned down in December.

article thumbnail

A history of blood cancer treatment

pharmaphorum

During his time working in the pathology museum at Guy’s Hospital in London, Hodgkin studied several preserved specimens of human organs affected by disease. The first well-documented case of multiple myeloma was reported in 1844 by renowned British surgeon Samuel Solly. 1942 – Chemotherapy moves from trenches to treatment .